Susquehanna Fundamental Investments, LLC Ionis Pharmaceuticals Inc Transaction History
Susquehanna Fundamental Investments, LLC
- $4.33 Trillion
- Q2 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 45,574 shares of IONS stock, worth $1.72 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
45,574
Previous 45,574
-0.0%
Holding current value
$1.72 Million
Previous $1.98 Billion
9.94%
% of portfolio
0.05%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding IONS
# of Institutions
395Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$524 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$478 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$390 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$312 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$248 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.37B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...